Holen Sie sich die Stockscreener-App
1.32
5.71%
-0.08
Handel nachbörslich:
1.33
0.01
+0.76%
Schlusskurs vom Vortag:
$1.40
Offen:
$1.47
24-Stunden-Volumen:
1.66M
Relative Volume:
26.76
Marktkapitalisierung:
$5.57M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.32M
KGV:
-0.1038
EPS:
-12.7107
Netto-Cashflow:
$-7.30M
1W Leistung:
+9.09%
1M Leistung:
-23.70%
6M Leistung:
-30.53%
1J Leistung:
-54.95%
1-Tages-Spanne:
$1.28
$1.66
1-Wochen-Bereich:
$1.174
$1.66
52-Wochen-Spanne:
$0.952
$6.39
Tharimmune Inc Stock (THAR) Company Profile
Firmenname
Tharimmune Inc
Sektor
Branche
Telefon
302-743-2995
Adresse
1200 ROUTE 22 EAST, BRIDGEWATER
Vergleichen Sie THAR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
THAR
Tharimmune Inc
|
1.32 | 6.33M | 0 | -9.32M | -7.30M | -12.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Tharimmune Inc Aktie (THAR) Neueste Nachrichten
Tharimmune expands IP portfolio for opioid countermeasure technology By Investing.com - Investing.com Australia
What indicators show strength in Tharimmune Inc.July 2025 Breakouts & Smart Money Movement Tracker - Newser
Tharimmune Secures Key Global Patents for TH-104, Laying Foundation for Broader Indications Following Initial Development as a National Security Medical Countermeasure Against Weaponized Fentanyl - Corsicana Daily Sun
Military-Grade Fentanyl Protection: Tharimmune's Drug Platform Secures Global Patent Shield Through 2040 - Stock Titan
Using data filters to optimize entry into Tharimmune Inc.July 2025 PostEarnings & Technical Confirmation Alerts - Newser
Multi factor analysis applied to Tharimmune Inc.2025 Breakouts & Breakdowns & Technical Pattern Recognition Alerts - Newser
What’s the recovery path for long term holders of Tharimmune Inc.2025 Performance Recap & Reliable Volume Spike Trade Alerts - Newser
Using data tools to time your Tharimmune Inc. exit2025 Market Outlook & Momentum Based Trading Signals - Newser
Using data tools to time your Tharimmune Inc. exit [2025 Analyst Calls]AI Driven Price Predictions - Newser
Tharimmune prices $1.74 million direct offering - MSN
What risks could impact Tharimmune Inc. stock performancePattern Recognition Tool for ROI Investors - Newser
Published on: 2025-08-12 04:27:10 - Newser
Chart based analysis of Tharimmune Inc. trendsLong-Term Investment Strategy Impact Analysis - Newser
Tharimmune Inc. stock trend outlook and recovery pathFree High Conviction Intraday Stock Signals - Newser
Using AI based signals to follow Tharimmune Inc.High Return Idea With Technical Filter - Newser
Applying Wyckoff theory to Tharimmune Inc. stockReal Stock Picks With Setup Verification - Newser
What machine learning models say about Tharimmune Inc.Free Secure Return Focused Investment Plan - Newser
Analyzing drawdowns of Tharimmune Inc. with statistical toolsReal-Time AI Generated Market Forecast - Newser
Using fundamentals and technicals on Tharimmune Inc.Long Term Stock Planner with Safety Checks - Newser
Has Tharimmune Inc. Stock Ever Crashed Historical Volatility ReviewMonthly Trade Result and Signal Summary - Newser
What makes Tharimmune Inc. stock price move sharplyEquity Forecast with Predictive AI Screener - Newser
Tharimmune Appoints Nancy Davis to Board of Directors - The Globe and Mail
Is Tharimmune Inc. showing insider buyingBest Value for High Returns - thegnnews.com
Tharimmune Issues Comprehensive Corporate Update including Lead TH104 as Critical National Security Solution Against Weaponized Fentanyl and TH023 Poised to Revolutionize Oral Antibody Delivery - The Florida Times-Union
Nancy Davis, Visionary Philanthropist and Founder of Race to Erase MS and Cure Addiction Now Appointed to the Tharimmune Board of Directors - Corsicana Daily Sun
Race to Erase MS Founder Who Raised $56M Joins Biotech Board to Fight Addiction Crisis - Stock Titan
Watch for Bullish Crossover in Tharimmune Inc.Alpha Driven Watchlist With Alerts Published - beatles.ru
Tharimmune Announces Pricing of $1.74 Million Registered Direct Public Offering of Common Stock and Warrants - Asbury Park Press
Tharimmune Advances Fentanyl Defense Solution, Breakthrough Oral Antibody Technology | THAR Stock News - Stock Titan
How does Tharimmune Inc. generate profit in a changing economyRemarkable growth - Jammu Links News
Finanzdaten der Tharimmune Inc-Aktie (THAR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):